GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (BSP:R1VT34) » Definitions » Cyclically Adjusted PB Ratio

Revvity (BSP:R1VT34) Cyclically Adjusted PB Ratio : 2.09 (As of Jun. 23, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Revvity Cyclically Adjusted PB Ratio?

As of today (2025-06-23), Revvity's current share price is R$18.66. Revvity's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was R$8.93. Revvity's Cyclically Adjusted PB Ratio for today is 2.09.

The historical rank and industry rank for Revvity's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:R1VT34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.07   Med: 4   Max: 8.04
Current: 2.2

During the past years, Revvity's highest Cyclically Adjusted PB Ratio was 8.04. The lowest was 2.07. And the median was 4.00.

BSP:R1VT34's Cyclically Adjusted PB Ratio is ranked worse than
55.07% of 138 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.755 vs BSP:R1VT34: 2.20

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Revvity's adjusted book value per share data for the three months ended in Mar. 2025 was R$13.153. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$8.93 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Revvity Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Revvity's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Cyclically Adjusted PB Ratio Chart

Revvity Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.55 7.70 4.47 2.99 2.68

Revvity Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.66 3.15 2.68 2.45

Competitive Comparison of Revvity's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted PB Ratio falls into.


;
;

Revvity Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Revvity's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=18.66/8.93
=2.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Revvity's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=13.153/134.9266*134.9266
=13.153

Current CPI (Mar. 2025) = 134.9266.

Revvity Quarterly Data

Book Value per Share CPI Adj_Book
201506 2.079 100.684 2.786
201509 2.559 100.392 3.439
201512 2.611 99.792 3.530
201603 2.483 100.470 3.335
201606 2.334 101.688 3.097
201609 2.266 101.861 3.002
201612 2.353 101.863 3.117
201703 2.246 102.862 2.946
201706 2.605 103.349 3.401
201709 2.574 104.136 3.335
201712 2.669 104.011 3.462
201803 2.705 105.290 3.466
201806 3.062 106.317 3.886
201809 3.398 106.507 4.305
201812 3.242 105.998 4.127
201903 3.264 107.251 4.106
201906 3.356 108.070 4.190
201909 3.585 108.329 4.465
201912 3.711 108.420 4.618
202003 4.327 108.902 5.361
202006 4.932 108.767 6.118
202009 5.571 109.815 6.845
202012 6.123 109.897 7.518
202103 7.188 111.754 8.678
202106 6.797 114.631 8.000
202109 10.396 115.734 12.120
202112 11.425 117.630 13.105
202203 10.125 121.301 11.262
202206 10.237 125.017 11.048
202209 10.483 125.227 11.295
202212 10.951 125.222 11.800
202303 11.863 127.348 12.569
202306 10.971 128.729 11.499
202309 11.002 129.860 11.431
202312 11.162 129.419 11.637
202403 11.300 131.776 11.570
202406 12.272 132.554 12.492
202409 12.833 133.029 13.016
202412 13.847 133.157 14.031
202503 13.153 134.927 13.153

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Revvity  (BSP:R1VT34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Revvity Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Revvity's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity Business Description

Traded in Other Exchanges
Address
77 4th Avenue, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity Headlines

No Headlines